Traws Pharma, Inc. (TRAW)
About Traws Pharma, Inc.
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $2.8M
- Net income
- $9.2M
- Total assets
- $10.6M
- Market cap
- $7.4M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $7.4M
- Shares outstanding
- 21.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 25, 2013
Traws Pharma, Inc. (TRAW) Stock Price
- Profitable — net income of $9.2M in FY2025.
- Trading 89% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Traws Pharma, Inc..
Write a review
News about Traws Pharma, Inc.
News & sentiment via Polygon.io
Traws Pharma, Inc.: frequently asked questions
Is Traws Pharma, Inc. an American company?
Traws Pharma, Inc. is a US-based company headquartered in Newtown, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Traws Pharma, Inc. headquartered?
Traws Pharma, Inc. is headquartered in Newtown, Pennsylvania, United States.
Is Traws Pharma, Inc. publicly traded?
Yes — Traws Pharma, Inc. is a publicly traded company. Its stock trades under the ticker symbol TRAW on the NASDAQ.
What does Traws Pharma, Inc. do?
Traws Pharma, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
